<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Elevai Labs, Inc. Common Stock — News on 6ix</title>
    <link>https://6ix.com/company/elevai-labs-inc-common-stock</link>
    <description>Latest news and press releases for Elevai Labs, Inc. Common Stock on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 23 Apr 2026 11:30:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/elevai-labs-inc-common-stock" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683562a778dffbe2df0eeec7.webp</url>
      <title>Elevai Labs, Inc. Common Stock</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock</link>
    </image>
    <item>
      <title>NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft Systems</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-defense-tech-acquires-patented-gps-denied-autonomous-drone-navigation-technology-option-built-for-defense-and-counter-unmanned-aircraft-systems</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-defense-tech-acquires-patented-gps-denied-autonomous-drone-navigation-technology-option-built-for-defense-and-counter-unmanned-aircraft-systems</guid>
      <pubDate>Thu, 23 Apr 2026 11:30:00 GMT</pubDate>
      <description>Patented Software Visual-Inertial Cooperative Navigation Technology has potential to Target Defense, Counter-Drone (C-UAS), Electronic Warfare, and Autonomous Unmanned Aircraft Systems Markets;Marks Second Contract Since Formation, Potentially Expanding Northstrive Defense Tech’s Portfolio; NEWPORT BEACH, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- NorthStrive Defense Tech LLC (“NorthStrive Defense Tech”), a wholly-owned subsidiary of PMGC Holdings Inc. (the “Company”) (NASDAQ: ELAB), today annou</description>
    </item>
    <item>
      <title>Univest Securities, LLC Announces a $40 Million Equity Line Facility for its Client PMGC Holdings, Inc. (NASDAQ: ELAB)</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/univest-securities-llc-announces-a-dollar40-million-equity-line-facility-for-its-client-pmgc-holdings-inc-nasdaq-elab</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/univest-securities-llc-announces-a-dollar40-million-equity-line-facility-for-its-client-pmgc-holdings-inc-nasdaq-elab</guid>
      <pubDate>Tue, 21 Apr 2026 21:00:00 GMT</pubDate>
      <description>New York, April 21, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a $40,000,000 equity line facility with an initial tranche of $10,000,000 (the “Offering”) for its client PMGC Holdings, Inc. (NASDAQ: ELAB) (the “Company”), a diversified holding company executing a targeted roll-up strategy in U.S.-based precision manufacturing. The pu</description>
    </item>
    <item>
      <title>SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/svm-machining-inc-signs-long-term-agreement-to-supply-mission-critical-aerospace-and-defense-components-to-turbo-jet-products-co-inc</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/svm-machining-inc-signs-long-term-agreement-to-supply-mission-critical-aerospace-and-defense-components-to-turbo-jet-products-co-inc</guid>
      <pubDate>Tue, 21 Apr 2026 11:30:00 GMT</pubDate>
      <description>Third Long-Term Agreement Signed by a PMGC Holdings Subsidiary in 2026, Reflecting Continued Growth in the Company’s Aerospace and Defense Supply Chain PresenceNEWPORT BEACH, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- SVM Machining, Inc. (d/b/a Silicon Valley Manufacturing) (“SVM”), an ISO 9001:2015 certified precision CNC machining company and wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced the execution of a Long-Term Agreement (“LTA”) with Turbo-Jet Products Co.,</description>
    </item>
    <item>
      <title>PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&amp;A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing Companies</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-nasdaq-elab-secures-dollar40-million-equity-purchase-facility-agreement-announces-ability-to-accelerate-manda-strategy-currently-focused-on-acquiring-aerospace-and-defense-manufacturing-companies</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-nasdaq-elab-secures-dollar40-million-equity-purchase-facility-agreement-announces-ability-to-accelerate-manda-strategy-currently-focused-on-acquiring-aerospace-and-defense-manufacturing-companies</guid>
      <pubDate>Fri, 17 Apr 2026 11:30:00 GMT</pubDate>
      <description>Approximately $10 Million To Be Funded at First Closing; 24-Month Commitment Period Provides Dedicated Capital to Execute on Active M&amp;A Pipeline Currently focused on Aerospace, Defense, and Industrial ManufacturingNEWPORT BEACH, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”), a diversified holding company executing a targeted roll-up strategy in U.S.-based precision manufacturing, today announced its entry into a $40 million equity purchase</description>
    </item>
    <item>
      <title>AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 Firm</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/aga-precision-systems-signs-second-long-term-supply-agreement-to-manufacture-aerospace-and-defense-components-for-a-tier-1-firm</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/aga-precision-systems-signs-second-long-term-supply-agreement-to-manufacture-aerospace-and-defense-components-for-a-tier-1-firm</guid>
      <pubDate>Thu, 09 Apr 2026 11:30:00 GMT</pubDate>
      <description>Signing of Second Long-Term Agreement with Major Aerospace and Defense Customer in 2026, Demonstrating Continued Customer Confidence and Contract MomentumNEWPORT BEACH, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- AGA Precision Systems LLC (“AGA”), an ITAR-registered and AS9100-certified precision CNC aerospace and defense manufacturing company and subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced the execution of a Long-Term Agreement (“LTA”) with globally recognized Tier 1 aerospa</description>
    </item>
    <item>
      <title>PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-nasdaq-elab-fully-utilizes-all-available-in-dollar20m-equity-financing-facility-strengthens-cash-position-and-advances-multi-sector-acquisition-strategy</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-nasdaq-elab-fully-utilizes-all-available-in-dollar20m-equity-financing-facility-strengthens-cash-position-and-advances-multi-sector-acquisition-strategy</guid>
      <pubDate>Wed, 08 Apr 2026 11:30:00 GMT</pubDate>
      <description>Facility Fully UtilizedCompany Maintains Strong Cash Position, Fully Funded for Near-Term Acquisition PipelinePortfolio Spans Aerospace, Defense, Semiconductor, Medical Device, and Data Center Supply Chains NEWPORT BEACH, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“the Company,” “PMGC,” “we,” or “our”), a diversified holding company, today announced that it has utilized all of the $20 million commitment amount under its equity purchase facility (the “Facility”)</description>
    </item>
    <item>
      <title>NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial Applications</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-defense-tech-acquires-multi-domain-drone-payload-technology-option-for-defense-and-commercial-applications</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-defense-tech-acquires-multi-domain-drone-payload-technology-option-for-defense-and-commercial-applications</guid>
      <pubDate>Mon, 06 Apr 2026 11:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- NorthStrive Defense Tech LLC (“NorthStrive Defense Tech”), a wholly-owned subsidiary of PMGC Holdings Inc. (the “Company”) (NASDAQ: ELAB), today announced it has acquired rights to a novel drone technology through an exclusive option agreement (“Option Agreement”) with a corporation. The Option Agreement provides NorthStrive Defense Tech with an exclusive option, within the aerospace and defense technologies field (“Field”), to get an exc</description>
    </item>
    <item>
      <title>PMGC Holdings Inc. Announces the Formation of New Subsidiary, NorthStrive Defense Tech to Target High-Growth Defense, Drone and Autonomous Systems Sector</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-the-formation-of-new-subsidiary-northstrive-defense-tech-to-target-high-growth-defense-drone-and-autonomous-systems-sector</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-the-formation-of-new-subsidiary-northstrive-defense-tech-to-target-high-growth-defense-drone-and-autonomous-systems-sector</guid>
      <pubDate>Thu, 02 Apr 2026 20:05:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC”) (NASDAQ: ELAB), a diversified holding company, today announced the launch of a new wholly owned subsidiary, NorthStrive Defense Tech LLC (“NorthStrive Defense Tech”). The Company plans for NorthStrive Defense Tech to operate in the defense technology sector, with an emphasis on drone technology, autonomous systems, and next generation unmanned defense solutions. NorthStrive Defense Tech has bee</description>
    </item>
    <item>
      <title>AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/aga-precision-systems-signs-long-term-agreement-to-supply-mission-critical-aerospace-and-defense-components-to-turbo-jet-products</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/aga-precision-systems-signs-long-term-agreement-to-supply-mission-critical-aerospace-and-defense-components-to-turbo-jet-products</guid>
      <pubDate>Tue, 31 Mar 2026 11:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- AGA Precision Systems LLC (“AGA”), a precision aerospace manufacturing company and wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), today announced the execution of a Long-Term agreement (“LTA”) with Turbo-Jet Products Co., Inc. (“Turbo-Jet Products”), a California-based aerospace and defense supplier. Under the terms of the LTA, AGA will supply mission-critical aerospace and defense components in support of Turbo-Jet Product</description>
    </item>
    <item>
      <title>PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-nasdaq-elab-reports-2025-annual-results-and-files-form-10-k-company-expands-asset-base-to-dollar138m-a-43percent-increase-from-2024</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-nasdaq-elab-reports-2025-annual-results-and-files-form-10-k-company-expands-asset-base-to-dollar138m-a-43percent-increase-from-2024</guid>
      <pubDate>Mon, 30 Mar 2026 11:03:00 GMT</pubDate>
      <description>Deploys Capital into Cash-Flowing Manufacturing Businesses in Aerospace, Defense and IT PackagingAdvances Dual Myostatin Assets Targeting Muscle Preservation in Potential Combination with GLP-1 Treatments NEWPORT BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“the Company,” “PMGC,” “we,” or “our”) today filed its Annual Report on Form 10-K (“Annual Report”) for the fiscal year ended December 31, 2025 (“FYE 2025”), with the U.S. Securities and Exchange Commis</description>
    </item>
    <item>
      <title>NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-signs-licensing-agreement-amendment-with-moa-life-plus-kosdaq-142760-for-dual-myostatin-assets-targeting-muscle-preservation-in-combination-with-glp-1-treatments</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-signs-licensing-agreement-amendment-with-moa-life-plus-kosdaq-142760-for-dual-myostatin-assets-targeting-muscle-preservation-in-combination-with-glp-1-treatments</guid>
      <pubDate>Fri, 27 Mar 2026 20:05:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc.’s (NASDAQ: ELAB) (“PMGC,” “we,” or “our”) wholly owned subsidiary, NorthStrive Biosciences Inc. (“Northstrive Biosciences”), announced today a third amendment (“Amendment”) to its existing License Agreement with MOA Life Plus Co., Ltd., [KOSDAQ: 142760] a Korean biotechnology company (“MOA,” and such existing agreement, as amended, “License Agreement”) Northstrive Biosciences holds for EL-32 and EL-22. The Amendment upd</description>
    </item>
    <item>
      <title>SVM Machining, Inc. Secures ITAR Registration, Enabling Entry into U.S. Defense Manufacturing Contracts</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/svm-machining-inc-secures-itar-registration-enabling-entry-into-us-defense-manufacturing-contracts</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/svm-machining-inc-secures-itar-registration-enabling-entry-into-us-defense-manufacturing-contracts</guid>
      <pubDate>Tue, 24 Mar 2026 11:00:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: PMGC) (“PMGC” or the “Company”), a diversified public holding company executing a targeted roll-up strategy in U.S.-based manufacturing, is pleased to announce that its wholly owned subsidiary, SVM Machining, Inc. dba Silicon Valley Manufacturing (“SVM”), has completed International Traffic in Arms Regulations (“ITAR”) registration and is in compliance with ITAR. The ITAR is administered by the U.S. State Depar</description>
    </item>
    <item>
      <title>NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss Therapy</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-announces-launch-of-el-32-preclinical-study-evaluating-muscle-preservation-in-glp-1-weight-loss-therapy-1</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-announces-launch-of-el-32-preclinical-study-evaluating-muscle-preservation-in-glp-1-weight-loss-therapy-1</guid>
      <pubDate>Tue, 10 Mar 2026 11:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”) today announced the initiation of a preclinical study for EL-32, an engineered probiotic candidate being developed by its wholly owned subsidiary, NorthStrive Biosciences Inc. (“NorthStrive Biosciences”). The study is designed to evaluate EL-32’s potential to preserve lean muscle mass while promoting fat loss, both as a standalone therapy and in combination with GLP-1 weight loss</description>
    </item>
    <item>
      <title>PMGC Holdings Inc. Announces Anticipated Reverse Stock Split</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-anticipated-reverse-stock-split-14</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-anticipated-reverse-stock-split-14</guid>
      <pubDate>Wed, 04 Mar 2026 22:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-6 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 12:00 am, Eastern time, on March 10, 2026. Key Details of the Reverse Stock Split: Conversion Ratio: Every 6 shares of issued and outstanding Common Stock will be consolidated into one</description>
    </item>
    <item>
      <title>NorthStrive Biosciences Files 10 U.S. Patent Applications for EL-22 and EL-32 Targeting Muscle Growth and Yield Enhancement in Farmed Animals</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-files-10-us-patent-applications-for-el-22-and-el-32-targeting-muscle-growth-and-yield-enhancement-in-farmed-animals</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-files-10-us-patent-applications-for-el-22-and-el-32-targeting-muscle-growth-and-yield-enhancement-in-farmed-animals</guid>
      <pubDate>Thu, 19 Feb 2026 12:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences, Inc. (“NorthStrive” or the “Company”), a wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), today announced the filing of ten (10) new U.S. patent applications expanding its proprietary EL-22 and EL-32 technologies into animal health and agricultural markets, including applications designed to encourage animals to grow new muscle and increase muscle weight return per animal. These ten (10) patent applica</description>
    </item>
    <item>
      <title>NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservation in Animal Health</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-signs-definitive-license-agreement-for-commercialization-of-el-22-and-el-32-a-myostatin-engineered-probiotic-for-muscle-preservation-in-animal-health</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-signs-definitive-license-agreement-for-commercialization-of-el-22-and-el-32-a-myostatin-engineered-probiotic-for-muscle-preservation-in-animal-health</guid>
      <pubDate>Wed, 11 Feb 2026 12:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. (“NorthStrive”), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced that it has executed a definitive, exclusive license agreement (“License Agreement”) with Modulant Biosciences LLC (“Modulant”), following the previously announced binding term sheet dated May 12, 2025. The License Agreement covers NorthStrive’s EL-22 and EL-32 assets and, pur</description>
    </item>
    <item>
      <title>NorthStrive Biosciences Announces Progress Updates to Phase III Timeline for AI-Driven Drug Discovery Program with Yuva Biosciences</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-announces-progress-updates-to-phase-iii-timeline-for-ai-driven-drug-discovery-program-with-yuva-biosciences</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/northstrive-biosciences-announces-progress-updates-to-phase-iii-timeline-for-ai-driven-drug-discovery-program-with-yuva-biosciences</guid>
      <pubDate>Wed, 04 Feb 2026 21:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. (“NorthStrive Biosciences”), a subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB) (“PMGC”), today announced a progress update to the anticipated completion timeline for Phase III of its AI Development Program with strategic partner Yuva Biosciences, Inc. (“Yuva Biosciences”). On December 17, 2025, Northstrive Biosciences announced the initiation of Phase III, which was expected to last approximately 6 to 9 weeks. N</description>
    </item>
    <item>
      <title>PMGC Holdings Inc. Announces the Acquisition of SVM Machining, Inc.</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-acquisition-123000335</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-acquisition-123000335</guid>
      <pubDate>Tue, 03 Feb 2026 12:30:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”), a diversified public holding company announced that it has completed the acquisition of SVM Machining, Inc. (“SVM”). Founded in 1997 by Mark Serpa, SVM (aka Silicon Valley Manufacturing) is a Northern California-based ISO 9001:2015 Certified CNC precision machining and manufacturing services company serving medical, aerospace, biotech &amp; pharmaceutical, semiconductor, and transpor</description>
    </item>
    <item>
      <title>PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc.</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-strategic-123000820</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-strategic-123000820</guid>
      <pubDate>Tue, 06 Jan 2026 12:30:00 GMT</pubDate>
      <description>The U.S. small and micro modular reactor (SMR/MMR) market is experiencing rapid growth, driven by energy security needs, data center demand, and federal...</description>
    </item>
    <item>
      <title>PMGC Holdings Inc. Announces Reverse Stock Split Effective January 6, 2026</title>
      <link>https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-reverse-stock-split-effective-january-6-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/elevai-labs-inc-common-stock/news/pmgc-holdings-inc-announces-reverse-stock-split-effective-january-6-2026</guid>
      <pubDate>Tue, 06 Jan 2026 04:00:00 GMT</pubDate>
      <description>NEWPORT BEACH, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that, as previously disclosed on January 2, 2026, it will effect a 1-for-4 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 9:00 am, Eastern time, on January 6, 2026. Key Details of the Reverse Stock Split: Conversion Ratio: Every 4 shares of issued and outstandin</description>
    </item>
  </channel>
</rss>